Insiders · FLGT

Michael Nohaile

Director at Fulgent Genetics, Inc. (FLGT) since August 2022

Michael Nohaile has filed 6 insider reports with the SEC since August 2022, as director at Fulgent Genetics, Inc. (FLGT). The latest filing, on May 18, 2026, reports grant or award at Fulgent Genetics, Inc. (FLGT).

Filings
6
Companies
1
Bought on market
None
Sold on market
None

Companies where Michael Nohaile is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
Fulgent Genetics, Inc. logo
FLGT
Fulgent Genetics, Inc.
Directorsince August 202224,578$24.12May 18, 2026

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.

Every filing

Compare Michael Nohaile with

Other insiders at the same companies

Questions about Michael Nohaile

What is Michael Nohaile's role at Fulgent Genetics, Inc.?
Michael Nohaile reports to the SEC as director at Fulgent Genetics, Inc. (FLGT), according to the latest filing on May 18, 2026.
How many shares does Michael Nohaile own?
After the latest filing that states it, Michael Nohaile directly owned 24,578 shares of Fulgent Genetics, Inc. (FLGT). Shares held through trusts, funds or family members are reported separately and are not counted here.
Has Michael Nohaile bought or sold stock recently?
No open-market purchases or sales by Michael Nohaile are on file. The filings report grant or award.
How do I get alerts when Michael Nohaile files?
Follow Michael Nohaile on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.

From SEC Forms 3, 4, 5 and 144 filed by Michael Nohaile (SEC CIK 0001890563). Totals count each trade once, skipping amendments whose original is on file, from Aug 10, 2022 on. View on SEC EDGAR · Get this as JSON